KUALA LUMPUR, Sept 30 (Bernama) — As the Government prepares to transition Malaysia into the endemic phase of COVID-19, AmMetLife Insurance Berhad (AmMetLife) will expand its support to new and existing medical plan customers by adding a COVID-19 Hospitalisation Reimbursement Benefit. This benefit will form part of the company’s COVID-19 Fund that has been increased to RM5 million from RM1 million.
As part of its commitment to protecting the health and well-being of its customers, AmMetLife will reimburse medical expenses received as a *Category three, four or five COVID-19 patient at a Ministry of Health designated hospital. The coverage period is effective from 1 September 2021 until 31 December 2021 or when the total payout for the AmMetLife COVID-19 Fund reaches RM5 million, whichever is earlier. All claims payable for this benefit will be on a first-come-first-served basis.